Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of Merck's Efinopegdutide?
Efinopegdutide is a synthetic peptide commercialized by Merck, with a leading Phase II program in Obesity. According to Globaldata, it...
Data Insights
Risk adjusted net present value: What is the current valuation of Merck's Efinopegdutide?
Efinopegdutide is a synthetic peptide commercialized by Merck, with a leading Phase II program in Type 2 Diabetes. According to...